Pregnancy protein puzzle: leucine needs under the microscope
NCT ID NCT07437248
First seen Feb 28, 2026 · Last updated Jun 22, 2026 · Updated 14 times
Summary
This study aims to find out how much leucine, a key protein building block, healthy pregnant women need during early and late pregnancy. Researchers will give 40 women special meals and collect breath, urine, and blood samples to track how their bodies use leucine. The results could help improve nutrition guidelines for pregnant women.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PREGNANCY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
BC Children's Hospital Research Institute
RECRUITINGVancouver, British Columbia, V5Z 4H4, Canada
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Leucine (an essential amino acid)
What this could lead to
If successful, this could lead to better dietary recommendations for leucine intake during pregnancy, supporting maternal and fetal health.
What could go wrong
This is a small, early-stage observational study with only 40 participants, so results may not apply to all pregnant women. It does not test a treatment or health outcome.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.